Autolus Therapeutics (AUTL) Net Income towards Common Stockholders Growth (3y) (2020 - 2025)
Autolus Therapeutics (AUTL) Net Income towards Common Stockholders Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 45.47% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 91.31% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Autolus Therapeutics | 393.78 Mn | 93.07 Mn | -1.04 Mn | -49.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -49.62% |
| Sep 30, 2025 | -22.76% |
| Jun 30, 2025 | -4.44% |
| Mar 31, 2025 | -23.71% |
| Dec 31, 2024 | 12.85% |
| Sep 30, 2024 | -34.17% |
| Jun 30, 2024 | -20.66% |
| Mar 31, 2024 | -16.57% |
| Dec 31, 2023 | -21.67% |
| Sep 30, 2023 | -7.14% |
| Jun 30, 2023 | -12.44% |
| Mar 31, 2023 | -10.05% |
| Jun 30, 2022 | 8.91% |
| Mar 31, 2022 | -10.89% |
| Dec 31, 2021 | -45.22% |
| Sep 30, 2021 | 8.75% |
| Jun 30, 2021 | -10.86% |
| Dec 31, 2020 | -78.57% |